Invention Grant
- Patent Title: Crystalline form of N-butyldeoxygalactonojirimycin
-
Application No.: US17479341Application Date: 2021-09-20
-
Publication No.: US11713297B2Publication Date: 2023-08-01
- Inventor: Vitor Oliveira , Ivan Pogorelic , Jean-Paul Roduit
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: Idorsia Pharmaceuticals Ltd
- Current Assignee: Idorsia Pharmaceuticals Ltd
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WO TEP2017063287 2017.06.01
- Main IPC: A61K9/48
- IPC: A61K9/48 ; C07D211/40
Abstract:
The invention relates to a crystalline form of [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)-piperidine-3,4,5-triol, processes for the preparation thereof, pharmaceutical compositions containing such a crystalline form, and its use as a medicament, especially as glycolipid biosynthesis inhibitor.
Public/Granted literature
- US20220002245A1 CRYSTALLINE FORM OF N-BUTYLDEOXYGALACTONOJIRIMYCIN Public/Granted day:2022-01-06
Information query
